SHERMAN IP LLP is Excited to Announce We Are Extending Our Offer For Reduced Attorney Fees Until January 31, 2025. Clients Can Secure Reduced Attorney Fees for Their Patent and Trademark Filings Facing Increases in Governmental Fees by the USPTO Effective January 18 and January 19, 2025.

We previously published that the United States Patent & Trademark Office (USPTO) is increasing trademark and patent fees effective January 18-19, 2025. We had also notified you that January 15, 2015 would be our firm's cut-off to secure the 2024 fee schedule for clients facing increased fees. We are pleased to ...

SHERMAN IP Launches a Cost-Effective Cancellation and Opposition Initiative to Protect Trademarks Rights

In our ongoing commitment to protect clients' trademark rights, SHERMAN IP LLP is excited to announce the launch of its new initiative designed to help businesses address Trademark Opposition or Cancellation Proceedings at the Trademark Trial and Appeal Board (TTAB) of the United States Patent and Trademark Office. This initiative further ...

SHERMAN IP – Wants to Know Your Opinion!

We're thrilled to announce an exciting new initiative at SHERMAN IP! We're reaching out to hear directly from our clients, vendors and all of our other partners about your experience with our firm and how we provide our legal services. We look to you as our partners and your constructive ...

NEW SHERMAN IP® LEGAL PRACTICE COMPONENT TRADEMARK SINGLE FLAT FEE FILING PROGRAM YOU CONTROL THE COST!™/ YOU CONTROL THE CASE!™

Sherman IP is proud to introduce a new legal product component developed in our Control Legal® system that aligns with Sherman IP’s consumer facing, low cost, pay-as-you-go, limited scope legal practice. Our newest Control Legal product, the “Single Flat Fee Trademark Filing Program”, is Sherman IP®’s fresh take on effective and ...

USPTO Issues Guidelines for Assessing Enablement in Utility Applications and Patents In view of the SCOTUS decision in Amgen Inc. et al. v. Sanofi et al.

In view of the recent, unanimous decision from the Supreme Court of the United States (SCOTUS) in Amgen Inc. et al. v. Sanofi et al., the United States Patent and Trademark Office (USPTO) has now provided “Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court ...